• +7 (495) 646-80-76

Gennady Margolit, Executive Director of the Moscow Exchange’s Innovation and Investment Market

Dear colleagues and conference participants!
On behalf of the Innovation and Investment Market of the Moscow Exchange and myself personally, I warmly welcome all participants and guests!

We see great prospects for the development of the life sciences sector in our country and the fact that this event is being held is a sign of its maturity. I believe that this conference is capable of serving as an important catalyst in the sector’s development, and it is certain to be of great use in consolidation of the efforts of all interested players.

We, as a securities exchange, see great potential in Russian life sciences companies as future flagships of growth and potential blue chip stocks on the Russian market. As a part of this event my colleagues and I plan to discuss specific professional issues concerning investment in biotech, including the use of stock market instruments. I wish all participants great success and effective, fruitful work.

Adam Kostyál

Dear participants!
As a representative for NASDAQ OMX I am honored to be invited as a speaker at the Moscow Life Science Investment Day. The timing and location of this conference really could not be better given the strong Russian business climate and investor appetite for life science companies.
At NASDAQ OMX we are currently seeing more activity in the life science space than we have in the last decade. In the U.S. 2013 was a record year for healthcare companies going public with 50 NASDAQ IPOs. And in the first quarter of 2014 we are already approaching this number, which bodes for another terrific year for life science companies raising capital in the public markets.
Moscow is quickly emerging as one of the life science start-up hubs in Europe. In support of this NASDAQ OMX and Moscow Exchange last year entered an agreement with the common goal of facilitating access to capital for the fast growing Russian start-up community. Our shared presence at this conference should be considered as an important step within this partnership.
As the world’s largest exchange group with over 3,000 listed companies worldwide, NASDAQ OMX has a unique expertise and network when it comes to supporting start-ups globally in raising capital to fund growth. We want to leverage this in order to support Russian start-ups to grow, and I already look forward to meeting with many new and exciting life science entrepreneurs in Moscow come June 18.